Evidence map›Paper›PMID 31952279›Full record

ArticleInternational journal of molecular sciences2020

Riboflavin Plays a Pivotal Role in the UVA-Induced Cytotoxicity of Fibroblasts as a Key Molecule in the Production of H

Satoshi Yoshimoto, Nana Kohara, Natsu Sato, Hideya Ando, Masamitsu Ichihashi

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 33 citations in OpenAlex.

  1. Riboflavin.Advances in nutrition (Bethesda, Md.) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Photochemoprevention of topical formulation containing purified fraction of Inga edulis leaves extract.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Satoshi YoshimotoDepartment of Applied Chemistry and Biotechnology, Okayama University of Science, Okayama 700-0005, Japan.
Nana KoharaDepartment of Applied Chemistry and Biotechnology, Okayama University of Science, Okayama 700-0005, Japan.
Natsu SatoDepartment of Applied Chemistry and Biotechnology, Okayama University of Science, Okayama 700-0005, Japan.
Hideya AndoDepartment of Applied Chemistry and Biotechnology, Okayama University of Science, Okayama 700-0005, Japan.
Masamitsu IchihashiAnti-Aging Medical Research Center, Doshisha University, Kyoto 610-0394, Japan.
Okayama University of Science · JPDoshisha University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate environmental factors that contribute to ultraviolet A (UVA)-induced oxidative stress, which accelerates the senescence and toxicity of skin cells, we irradiated human fibroblasts cultured in commonly used essential media with UVA and evaluated their viability and production of reactive oxygen species. The viability of fibroblasts exposed to a single dose of 3.6 J/cm

Indexed as

Ultraviolet RaysAmino AcidsCells, CulturedCell SurvivalCulture MediaFibroblastsForeskinHumansHydrogen PeroxideInfant, NewbornMaleOxidation-ReductionOxidative StressPhotosensitizing AgentsRiboflavinVitaminsAmino AcidsCulture MediaHydrogen PeroxidePhotosensitizing AgentsRiboflavinVitaminsfibroblasthydrogen peroxidephoto-agingphotosensitizationsinglet oxygensuperoxideUVA

Identifiers

PMID31952279
PMCPMC7013916
OpenAlexW2999627965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.